Form 8-K - Current report:
SEC Accession No. 0001005286-23-000087
Filing Date
2023-05-23
Accepted
2023-05-22 21:57:17
Documents
19
Period of Report
2023-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20230522.htm   iXBRL 8-K 75893
2 EX-10.1 exhibit101-creditguarantya.htm EX-10.1 1131848
3 EX-10.2 exhibit102-pledgeandsecuri.htm EX-10.2 363722
4 EX-10.3 exhibit103-limitedwaiverco.htm EX-10.3 1903890
5 EX-10.4 exhibit104-haequipmentsale.htm EX-10.4 68142
6 EX-10.5 exhibit105-haequipmentleas.htm EX-10.5 102343
7 EX-10.6 exhibit106-arsupplyagreeme.htm EX-10.6 166114
8 EX-99.1 ex991-pressreleasedated522.htm EX-99.1 13544
  Complete submission text file 0001005286-23-000087.txt   4600882

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20230522.xsd EX-101.SCH 1981
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20230522_lab.xml EX-101.LAB 24137
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20230522_pre.xml EX-101.PRE 12589
13 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20230522_htm.xml XML 11086
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 23946410
SIC: 2834 Pharmaceutical Preparations